A longitudinal study of the factors that influence patients’ medication adherence at the start of cardiac rehabilitation (CR) and 6 months later by Thomson, Patricia et al.
A longitudinal study of the factors that influence 
patients’ medication adherence at the start of cardiac 
rehabilitation (CR) and 6 months later
Introduction
Purpose 
 Non-adherence to prescribed medications is common 
among cardiac patients (Maddox & Ho 2009)
 Self-reports of medication non-adherence are strongly 
associated with adverse cardiac events including CHD 
death, MI and stroke (Ho et al. 2008)
 Patterns of medication taking behavior may be linked 
to other behaviours and conditions such as motivation, 
capability and opportunity (CR)
 There is limited knowledge of the associations 
between patients’ illness perceptions, beliefs about 
CR, quality of life and medication adherence
 To compare changes in patients medication 
adherence at the start of CR (TP1) and 6 months 
(TP2)
 To examine the associations between patients’ illness 
perceptions, beliefs about CR and quality of life at 
TP1 and medication adherence at TP2
Conclusion 
 Greater perceived barriers to CR were related to lower levels of medication 
adherence (MMAS)
 Overall there was sub-optimal medication adherence in this group of CR 
patients which is disappointing considering the risk post ACS
 Although there was no intentional non-adherence, 11 patients (27.5%) were 
non-intentionally non-adherent i.e. forgot to take their medication (MARS-5)
 17 of patients reported medium to low levels of adherence at 6 months 
 There were differences in self-reported adherence between the two scales, 
MARS and MMAS-8, which warrants further investigation
 More longitudinal research is needed with a larger sample size to explore 
whether illness perceptions and other beliefs about CR are associated with 
medication adherence
Methods
 Design & sample: Longitudinal, descriptive study of 
patients with a diagnosis of acute coronary 
syndrome (ACS) recruited from a CR service at 
Raigmore Hospital, NHS Highland
 Data Collection: At start of CR programme (TP1) and 
6 months later (TP2)
 Measures: Medication Adherence Report Scale 
(MARS-5) (Horne 2004); Morisky Medication 
Adherence Scale (MMAS–8) (Morisky et al. 2008); 
Brief Illness Perceptions Scale (B-IPQ ) (Broadbent 
et al. 2006), Beliefs about CR Questionnaire (BCR) 
(Cooper et al. 2007) and the SF-12 Health Survey 
(SF–12) (Ware et al. 2005)
 Data analysis: Descriptive statistics, chi squares, 
independent sample t test, Spearman’s correlations, 
logistic regression (low vs medium / high adherers)
Results
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 40 patients with a diagnosis of ACS (70% male, 
mean age = 62.3 years (SD 7.8 years)
 Patients’ physical health score at TP1 (SF-12) -
mean 47.03 (SD 8.2) and mental health - mean 
47.58 (SD 8.8) i.e. both dimensions scoring below 
the population average of 50.
 Patients’ perceived practical barriers to CR at baseline were moderately 
negatively correlated with levels of adherence at 6 months (r = -.355, p = 
0.025) (MMAS-8)
 Results indicated greater perceived practical barriers to CR were related to 
lower levels of medication adherence
 Patients’ total scores for MARS-5 and MMAS-8 were strongly positively 
correlated at 6 months (r = .593, p<0.001)
Patients’ medication adherence 
Correlations among illness perceptions, beliefs about CR and QoL
Patients illness perceptions and beliefs
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• For illness perceptions (B-IPQ) there were higher scores for perceived 
consequences and lower scores for personal control compared to previous 
populations of MI patients on hospital discharge (Broadbent et al. 2006)
• For beliefs about CR (BCR) the scores for necessity were higher compared to 
Cooper et al. (2007) and lower for concerns about exercise, practical barriers 
and perceived suitability
• No significant changes in patients’ total scores on 
MARS-5 and MMAS-8 from baseline to 6 months
Unintentional and intentional non-adherence
• MARS-5 distinguishes between unintentional and intentional non-adherence to 
medication
• Results suggest no intentional / conscious non-adherence e.g. not taking 
medication causing side effects by patients at TP1 or TP2
• Most patients reported ‘never’ being unintentionally non-adherent i.e. forgetful at 
TP1 or TP2
• Patients that they were ‘sometimes’ or ‘rarely’ unintentionally non-adherent at TP1 
and TP2 but never ‘always’ or ‘often’
Specific medicine taking behaviours
• The 8 item MMAS measures specific medication taking behaviours. 3 categories 
of adherence are high (score, 8), medium (score, 6 to <8) and low (score, 6)
• Most patients (55.0 – 57.5%) had high levels of adherence at TP1 and TP2. 
• At 6 months, more patients reported medium adherence compared to baseline 
(40% v 35%) and at 6 months less patients reported low adherence than baseline 
(2.5 vs 10.0%) (Fig 1)
Regression Analysis
No significant (baseline) predictors of medication adherence at 6 months
Figure 1: Level of adherence at baseline and 6 months
